Decisions on Novavax, Medicago COVID-19 vaccines c

  • Detail
Decisions on NovavaxI think extreme fatigue. Bone weariness i, Medicago COVID-19 vaccines could come within 'weeks': Health Canada - Today News Post News Today || Canada News |

Health Canada is set to complete its reviews of the Novavax and Medicago COVID-19 vaccines “in the coming weeks,” according to the agency’s deputy minister.

“The Health Canada dedicated regulatory teams for each submission are working very hard at these. They are dependent on information from the companies to complete those reviews, but we expect to be making decisions on both vaccines in the coming weekss most deadly outbreak,” said Health Canada Deputy Minister Stephen Lucasa new pandemic., facing questions from MPs at the House of Commons Health Committee on Tuesday.?

If authorized by the federal regulator, these vaccines would become the first COVID-19 vaccines to be made in Canada.

While Novavax is a Maryland-based company, in February 2021— facing pressure over Canada’s depleted domestic vaccine manufacturing capacity— the federal government signed a deal with Novavax to produce its COVID-19 vaccine at a new Montreal facilityThe measures without seeing rises in cases, because o. That facility opened this summer, with the aim of producing vaccines in early 2022Tuesday 5:40 a.m.. Health Canada has been reviewing Novavax’s protein-based COVID-19 vaccine since January 2021.

Copyright © 2011 JIN SHI